BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2021 9:46:23 AM | Browse: 1009 | Download: 2566
Publication Name World Journal of Gastroenterology
Manuscript ID 62639
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells
Manuscript Source Invited Manuscript
All Author List Qiu-Ju Han, Yong-Liang Mu, Hua-Jun Zhao, Rong-Rong Zhao, Quan-Juan Guo, Yu-Hang Su and Jian Zhang
ORCID
Author(s) ORCID Number
Qiu-Ju Han http://orcid.org/0000-0002-6511-2308
Yong-Liang Mu http://orcid.org/0000-0001-8581-0851
Hua-Jun Zhao http://orcid.org/0000-0001-6619-8329
Rong-Rong Zhao http://orcid.org/0000-0001-7709-6256
Quan-Juan Guo http://orcid.org/0000-0002-4317-7303
Yu-Hang Su http://orcid.org/0000-0002-1155-8865
Jian Zhang http://orcid.org/0000-0001-5106-1397
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation of China 81972694
National Natural Science Foundation of China 81972686
Corresponding Author Jian Zhang, PhD, Dean, Professor, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, No. 44 Wenhua West Road, Jinan 250012, Shandong Province, China. zhangj65@sdu.edu.cn
Key Words Liver fibrosis; Natural killer cells; Fasudil; Hepatic stellate cells
Core Tip Liver fibrosis is caused by inflammation and characterized by accumulation of extracellular matrix, there is no clinically safe and efficient drug to treat liver fibrosis. Fasudil treatment inhibits liver injury and liver fibrosis in vivo, it prevents liver fibrosis via activating natural killer cells but suppressing hepatic stellate cells in Thioacetamide-induced model. As a drug used clinically, these provide a feasible solution for clinical treatment of liver fibrosis.
Publish Date 2021-06-25 09:46
Citation Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ, Su YH, Zhang J. Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells. World J Gastroenterol 2021; 27(24): 3581-3594
URL https://www.wjgnet.com/1007-9327/full/v27/i24/3581.htm
DOI https://dx.doi.org/10.3748/wjg.v27.i24.3581
Full Article (PDF) WJG-27-3581.pdf
Full Article (Word) WJG-27-3581.docx